首页» English» Professor»
 
Prof. Zhang Qiang
发布日期:2011-11-03 浏览次数: 字号:[ ]
 

Professor Qiang Zhang

Chief Scientist of National "973" Key Basic Research Project

Deputy director of The State Key Laboratory of Natural and Biomimetic Drugs

Tel: +86-10-82802791

Fax: +86-10-82802791

E-mail:zqdodo@bjmu.edu.cn

Lab Website: http://sklnbd.bjmu.edu.cn/qianglab/

 

Dr. Qiang Zhang is a professor of Department of Pharmaceutics in School of Pharmaceutical Sciences, Peking University. He received his PhD degree in School of Pharmacy, West China University of Medical Sciences and joined the School of Pharmaceutical Sciences, Peking University in August 1992.

 

Research Interests

 

Molecular Pharmaceutics

Targeted Drug Delivery System

Combination Cancer Therapy

Nanotechnology

 

Honors/Awards

 

2011   Founder Teaching Award- Outstanding Teacher Award

2009   First Award for Achievements in Natural Science from Ministry of Education of China (the secondary accomplished people )

2008   First prize of the Jieping Wu-Paul Jansseen Prize

2008   First prize of The Science and Technology Award of Chinese Pharmaceutical Association

2007   Outstanding Talent Award from Ministry of Education of China

2003  Second Award for Achievements in Natural Science from Ministry of Education of China

2003   China Pharmaceutical Development Award

2000   Century Talent Fund Award for the Ministry of Education of China

 

Professional Service

 

Member of Drug Evaluation Committee of SFDA

The First President of China Chapter, Controlled Release Society

Chair of Pharmaceutics Committee,Chinese Pharmaceutical Association (CPA)

Member of the editorial board of Journal of Controlled release

Vice-Editor of Acta Pharma. Sinica and Chinese of Pharm. J

Vice Head of Pharmaceutics Committee, China pharmacopoeia

Board member of J Microencapulation

 

Lastest Publications

 

1.    Xiang Y, Liang L, Wang X, Wang J, Zhang X, Zhang Q*. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. J Control Release. 2011,152(3): 402-410

2.    Wang Y, Yang T, Wang X, Dai W, Wang J, Zhang X, Li Z, Zhang Q*. Materializing sequential killing of tumor vasculature and tumor cells via targeted polymeric micelle system. J Control Release. 2011,149 (3):299-306

3.    Wang F, Zhang D*,Zhang Q*, Chen Y, Zheng D, Hao L, Duan C, Jia L, Liu G, Liu Y. Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance. Biomaterials. 2011,32:9444-9456

4.    Yang T, Wang Y, Li Z, Dai W, Yin J, Liang L, Ying X, Zhou S, Wang J, Zhang X, Zhang Q. Targeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculature. Nanomedicine:NBM. 2011 May 20. [Epub ahead of print]

5.    Zhang Y, Wang X, Wang J, Zhang X, Zhang Q. Octreotide-modified polymeric micelles as potential carriers for targeted docetaxel delivery to somatostatin receptor overexpressing tumor cells. Pharm Res. 2011 May;28(5):1167-78. Epub 2011 Feb 22.

6.    Jia Z, Lin P, Xiang Y,  Wang X, Wang J, Zhang X, Zhang Q*. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate. European J Pharma Biopharm. 2011,79(1):126-134

7.    Zhang H, Hollis C P, Zhang Q*, Li T *. Preparation and antitumor study of camptothecin nanocrystals. Int J Pharma. 2011, 415 (1-2): 293-300

8.    Wang XQ, Fan JM, Liu YO, Zhao B, Jia ZR, Zhang Q. Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat. Int J Pharm. 2011 Aug 9. [Epub ahead of print]

9.    Liu H, Liu Y*, Ma Z, Wang J, Zhang Q*. A Lipid Nanoparticle System Improves siRNA Efficacy in RPE Cells and a Laser-Induced Murine CNV Model. Invest Ophth Vis Sci, 2011, 52(7):4789-4794

 




打印本页 关闭窗口